F10 and acute respiratory distress syndrome: Patients who develop ventilator-associated pneumonia (VAP) have increased BALF levels of soluble TF and FVII, and moreover, increased BALF levels of soluble TF, FVIIa and FXa have been demonstrated in patients with ARDS [115].